Cantor Fitzgerald reiterates Neutral rating on Rivian stock at $19

Cantor Fitzgerald reiterated a Neutral rating on Rivian with a $19 price target, above the current $15.63 share price and InvestingPro’s $16.46 fair value. The new R2 launch, initial deliveries, and autonomy roadmap are constructive, with 2Q deliveries expected at 10,234 and 2025 production at 42,284 vehicles, but profitability remains weak with gross margin near 1% and a federal NHTSA probe over a possible rear toe link defect covering about 115,000 vehicles. Management still targets 62,000 to 67,000 deliveries in fiscal 2026, including EDVs.

Analysis

RIVN is increasingly a two-part story: the market is still pricing it like a struggling legacy EV OEM, while the company is trying to re-rate itself toward a software-enabled platform with better mix and optionality. The near-term setup is less about whether R2 is ‘good’ and more about whether initial conversion rates and reservation quality prove this can absorb fixed costs faster than the current burn trajectory implies. If that happens, the stock can move on multiple expansion before the P&L fully catches up; if not, the launch becomes another capital-intensive proof point with limited margin relief.

The more interesting second-order effect is competitive pressure on mid-size EV pricing. R2 at this level forces attention onto incumbents and start-ups that are still leaning on higher ASPs or incentive-heavy demand generation; that could compress gross profit expectations across the segment, especially for names relying on consumer affordability to hold volumes. On the supply chain side, any meaningful ramp benefits battery, electronics, and autonomy-adjacent vendors, but it also raises execution risk because early-volume launches often expose component quality and warranty costs before scale economics kick in.

The legal overhang is underappreciated because it hits both economics and narrative at the same time. A safety probe into a meaningful installed base can suppress trade-in values, slow new purchases, and force management to spend on remediation just as it is trying to prove margin discipline. Even if the issue is contained, the market tends to apply a valuation discount to EV brands when reliability becomes part of the discussion, and that discount can persist for quarters rather than days.

Consensus appears split between ‘cheap optionality’ and ‘profitable growth is still years away,’ which suggests the stock may be fairly valued only if R2 execution is clean and autonomy milestones remain on schedule. The contrarian opportunity is not an outright long in isolation, but a relative trade against peers that have less product-cycle catalyst and similar execution risk. Uber is the cleaner beneficiary of Rivian’s autonomy narrative because it monetizes fleet utilization without carrying manufacturing risk.

Key Decisions for Investors

• Long RIVN only as a catalyst trade into the first 60-90 days of R2 delivery data; size modestly and use a 15-20% stop if early order conversion or delivery cadence disappoints.
• Prefer a pair trade: long UBER / short RIVN over 3-6 months. Uber gets paid if Rivian’s autonomy story gains credibility, while Rivian bears hardware, warranty, and recall risk; this offers cleaner exposure to the mobility-autonomy theme.
• Buy RIVN calls only on a pullback after the first post-launch data print, not into strength. The risk/reward improves if the market over-discounts the NHTSA probe and gives you volatility at a lower implied premium.
• Avoid chasing the name until there is evidence that R2 improves gross margin trajectory by at least 200-300 bps sequentially; without that, upside is mostly narrative and downside is dilution risk.
• For relative value, monitor suppliers and autonomy beneficiaries rather than the OEM itself; if Rivian execution improves, the second-order winner is likely the ecosystem, not necessarily the equity with the highest balance-sheet risk.